I
107TH CONGRESS
1ST SESSION
H. R. 3138
To establish a club drug taskforce, and to authorize grants to expand
prevention efforts regarding the abuse of club drugs.
IN THE HOUSE OF REPRESENTATIVES
OCTOBER 16, 2001
Mr. GRAVES introduced the following bill; which was referred to the
Committee on Energy and Commerce
A BILL
To establish a club drug taskforce, and to authorize grants
to expand prevention efforts regarding the abuse of club
drugs.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Comprehensive Club
Drug Abuse Reduction Act’’.
TITLE I—INTERAGENCY CLUB
DRUG TASK FORCE
SEC. 101. INTERAGENCY TASK FORCE.
(a) ESTABLISHMENT.—There is established a ‘‘Club
Drug Task Force’’ (referred to in this title as the ‘‘inter-
agency task force’’) which shall consist of the following
members:
(1) The Attorney General, or a designee, who
shall serve as chair.
(2) 2 representatives selected by the Attorney
General.
(3) The Secretary of Education or a designee.
(4) The Secretary of Health and Human Serv-
ices or a designee.
(5) 2 representatives of State and local law en-
forcement and regulatory agencies, to be selected by
the Attorney General.
(6) 2 representatives selected by the Secretary
of Health and Human Services.
(7) 5 nongovernmental experts in drug abuse
prevention and treatment to be selected by the At-
torney General.
(b) RESPONSIBILITIES.—The interagency task force
shall be responsible for designing, implementing, and eval-
uating the education and prevention and treatment prac-
tices and strategies of the Federal Government in conjunc-
tion with State, local, and community leaders with respect
to club drugs and other synthetic stimulants.
(c) MEETINGS.—The interagency task force shall
meet at least once every 6 months.
(d) FUNDING.—The administrative expenses of the
interagency task force shall be paid out of existing Depart-
ment of Justice appropriations.
(e) FACA.—The Federal Advisory Committee Act (5
U.S.C. App. 2) shall apply to the interagency task force.
(f) TERMINATION.—The interagency task force shall
terminate 4 years after the date of enactment of this Act.
SEC. 102. PUBLIC HEALTH MONITORING.
The Secretary of Health and Human Services shall
develop a public health monitoring program to monitor
club drugs in the United States. The program shall in-
clude the collection and dissemination of data related to
club drug abuse which can be used by public health offi-
cials in policy development.
SEC. 103. DEFINITION.
As used in this title, the term ‘‘club drug’’ means a
primary 
synthetic 
that 
includes 
3,4-
methylenedioxymethamphetamine (MDMA), Katamine,
Gamma Hydroxybutyrate (GHB), Gamma Butyrolactone
(GBL), 
Flunitrazepam 
(Rohypnol), 
d-lysergic 
acid
diethylamide (LSD), Phencyclidine (PCP), or meth-
amphetamine.
TITLE 
II—EXPANDING 
CLUB
DRUG 
ABUSE 
PREVENTION
EFFORTS
SEC. 201. GRANTS BY CENTER FOR SUBSTANCE ABUSE PRE-
VENTION.
Section 515 of the Public Health Service Act (42
U.S.C. 290bb–21) is amended by adding at the end the
following subsection:
‘‘(e) PREVENTION OF CLUB DRUG ABUSE AND AD-
DICTION.—
‘‘(1) GRANTS.—The Director of the Prevention
Center may make grants to and enter into contracts
and cooperative agreements with public and non-
profit private entities to enable such entities—
‘‘(A) to carry out school-based programs
concerning the dangers of club drug abuse and
addiction, using methods that are effective and
evidence-based, including initiatives that give
students the responsibility to create their own
anti-drug abuse education programs for their
schools; and
‘‘(B) to carry out community-based club
drug abuse and addiction prevention programs
that are effective and evidence-based.
‘‘(2) USE OF FUNDS.—Amounts made available
under a grant, contract or cooperative agreement
under paragraph (1) shall be used for planning, es-
tablishing, or administering club drug prevention
programs in accordance with paragraph (3).
‘‘(3) PREVENTION
PROGRAMS
AND
ACTIVI-
TIES.—
‘‘(A) IN
GENERAL.—Amounts provided
under this subsection may be used—
‘‘(i) to carry out school-based pro-
grams that are focused on those districts
with high or increasing rates of club drug
abuse and addiction and targeted at popu-
lations which are most at risk to start club
drug abuse;
‘‘(ii) to carry out community-based
prevention programs that are focused on
those populations within the community
that are most at-risk for club drug abuse
and addiction;
‘‘(iii) to assist local government enti-
ties to conduct appropriate club drug pre-
vention activities;
‘‘(iv) to train and educate State and
local law enforcement officials, prevention
and education officials, members of com-
munity anti-drug coalitions and parents on
the signs of club drug abuse and addiction
and the options for treatment and preven-
tion;
‘‘(v) for planning, administration, and
educational activities related to the preven-
tion of club drug abuse and addiction;
‘‘(vi) for the monitoring and evalua-
tion of club drug prevention activities, and
reporting and disseminating resulting in-
formation to the public; and
‘‘(vii) for targeted pilot programs with
evaluation components to encourage inno-
vation and experimentation with new meth-
odologies.
‘‘(B) PRIORITY.—The Director of the Pre-
vention Center shall give priority in making
grants under this subsection to rural and urban
areas that are experiencing a high rate or rapid
increases in club drug abuse and addiction.
‘‘(4) ANALYSES AND EVALUATION.—
‘‘(A) 
IN
GENERAL.—Not 
less 
than
$500,000 of the amount available in each fiscal
year to carry out this subsection shall be made
available to the Director of the Prevention Cen-
ter, acting in consultation with other Federal
agencies, to support and conduct periodic anal-
yses and evaluations of effective prevention pro-
grams for club drug abuse and addiction and
the development of appropriate strategies for
disseminating information about and imple-
menting these programs.
‘‘(B) ANNUAL REPORTS.—The Director of
the Prevention Centers shall submit to the
Committee on Energy and Commerce and Com-
mittee on Appropriations of the House of Rep-
resentatives, and the Committee on Health,
Education, Labor, and Pensions and the Com-
mittee on Appropriations of the Senate, an an-
nual report with the results of the analyses and
evaluation under subparagraph (A).
‘‘(5) DEFINITION.—For purposes of this sub-
section, the term ‘club drug’ means a primary syn-
thetic 
that 
includes 
3,4-
methylenedioxymethamphetamine 
(MDMA),
katamine, gamma hydroxybutyrate (GHB), gamma
butyrolactone (GBL), flunitrazepam (Rohypnol), d-
lysergic acid diethylamide (LSD), phencyclidine
(PCP), or methamphetamine.
‘‘(6) AUTHORIZATION
OF
APPROPRIATIONS.—
For the purpose of carrying out this subsection,
there are authorized to be appropriated such sums
as may be necessary for fiscal year 2002 and each
subsequent fiscal year.’’.
Æ